Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments [Seeking Alpha]
Innate's lacutamab gains FDA breakthrough therapy designation [Yahoo! Finance]
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome [Yahoo! Finance]
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome